Matthew Kent Topham

University Of Utah

$3,852,545

Attributed

$3,852,545

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $577K · FY2005–14

$1M$750K$500K$250K$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

Funding mix

By agency

NIH$3,852,545 · 2

By mechanism

R01$2,395,098 · 1

P01$1,457,447 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Utah

Same institution · by research overlap

Ken R Smith$12,200,387
Randall Walter Burt$9,014,360
Thomas M McIntyre$16,430,367
Melinda Angus-Hill$622,904
David M Virshup$5,443,203

Others in their field

Top investigators on “Tumor Growth”

David Heimbrook · Leidos Biomedical Research, Inc.$146,387,105
Israel David Goldman · Yeshiva University$49,502,983
Candace S Johnson · University Of Pittsburgh At Pittsburgh$44,839,363
C Kent Osborne · Baylor College Of Medicine$40,237,256
Alan F Horwitz · University Of Virginia Charlottesville$39,846,480
Douglas Yee · University Of Minnesota$38,475,268

Research focus

Tumor GrowthEpidermal Growth Factor ReceptorMediatingTumorigenesisCellsEnzymesGrowthIn VivoTumorAffectReceptor SignalingPublic Health Medicine (Field)Cell ProliferationCell Differentiation ProcessBaseAttenuatedCarcinogenesisColonic NeoplasmsCancer TypeColorectal NeoplasmsCancer TherapyColon CarcinogenesisApoptosisColon